Screener
Lantern Pharma LTRN Q2 2025 earnings
Reported August 13, 2025 · Before market open
EPS-$0.40Beat by $0.13
EPS estimate-$0.53
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.35
Versus estimates
Diluted EPS
FAQ
- When did Lantern Pharma report Q2 2025 earnings?
- Lantern Pharma (LTRN) reported Q2 2025 earnings on August 13, 2025 before market open.
- What were Lantern Pharma's Q2 2025 revenue and EPS?
- Lantern Pharma reported eps of $-0.40 for Q2 2025.
- Did Lantern Pharma beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.53 by $0.13.
- How did Lantern Pharma's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 13.0% from $-0.46.
- Where can I find Lantern Pharma's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001641172-25-023489) and the 10-Q periodic report (0001641172-25-023471) directly on SEC EDGAR. The filing index links above go to sec.gov.
